BOSULIF
- Product NDC
- 0069-1014
- 11-digit product format
- 000691014
- Labeler code
- 0069
- Product ID
- 0069-1014_ca8600d9-46e6-402d-89f9-bc6a156bf751
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bosutinib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- NDA217729
- Marketing category
- NDA
- Marketing start
- 2024-01-02
- Substance
- BOSUTINIB MONOHYDRATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- BOSULIF
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BOSUTINIB MONOHYDRATE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 844ZJE6I55 |
| Rxcui | 1307624, 1307630, 1307633, 1307635, 1987732, 1987734, 2669663, 2669665, 2672326, 2672328 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0069-1014-15 | BOSULIF | 150 in 1 BOTTLE | CAPSULE | 150 | | 32 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| BOSUTINIB MONOHYDRATE | ACTIVE INGREDIENT | 844ZJE6I55 | BOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 8 | |
| BOSUTINIB | ACTIVE MOIETY | 5018V4AEZ0 | BOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 8 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | BOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 8 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | BOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 8 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | BOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 8 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | BOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 8 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | BOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 8 | |
| POLOXAMER 188 | INACTIVE INGREDIENT | LQA7B6G8JG | BOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 8 | |
| POLYETHYLENE GLYCOL 3350 | INACTIVE INGREDIENT | G2M7P15E5P | BOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 8 | |
| POLYVINYL ALCOHOL | INACTIVE INGREDIENT | 532B59J990 | BOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 8 | |
| POVIDONE K25 | INACTIVE INGREDIENT | K0KQV10C35 | BOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 8 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | BOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 8 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | BOSULIF (BOSUTINIB MONOHYDRATE) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC] | 8 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0069-1014 | BOSULIF (BOSUTINIB) TABLET, FILM COATED BOSULIF (BOSUTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | 31 | Current NDC, 1 package rows | 20241215_adc84ad5-a04d-4fee-9ba8-91f7abd928e3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0069-1014-15 | 00069101415 | 150 CAPSULE in 1 BOTTLE (0069-1014-15) | 150 capsule | 2024-01-02 | No | No | Current |